Comparison of the efficacy and safety of pregabalin for postherpetic neuralgia in Chinese and international patients

article

Comparison of the efficacy and safety of pregabalin for postherpetic neuralgia in Chinese and international patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2147/JPR.S157856
P932PMC publication ID6126478
P698PubMed publication ID30214280

P2093author name stringLi Xie
Bruce Parsons
Xiaoping Pan
Marie Ortiz
Ed Whalen
YuXuan Chen
P2860cites workEfficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trialQ39355231
Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimensQ39366709
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scaleQ40678235
Epidemiology and cost of herpes zoster and postherpetic neuralgia in GermanyQ42281395
Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trialQ44411545
Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.Q44843017
A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Pregabalin for Postherpetic Neuralgia in a Population of Chinese PatientsQ47905583
Examining the Time to Improvement of Sleep Interference With Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy and Postherpetic NeuralgiaQ48026447
Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in ChinaQ48310417
Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United KingdomQ56768031
The impact of herpes zoster and post-herpetic neuralgia on quality of life: patient-reported outcomes in six European countriesQ84598585
A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine IntroductionQ28112193
Time to onset of neuropathic pain reduction: A retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgiaQ33555854
Systematic review of incidence and complications of herpes zoster: towards a global perspective.Q33795551
Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based studyQ34064838
The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective studyQ34273914
Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain.Q35607755
Comorbidities in chronic neuropathic painQ35680402
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendationsQ37022616
Systematic review and meta-analysis of pharmacological therapies for pain associated with postherpetic neuralgia and less common neuropathic conditionsQ38201876
Clinical practice. Postherpetic neuralgiaQ38260446
Post-herpetic Neuralgia: a Review.Q38734753
Improvement in pain severity category in clinical trials of pregabalinQ39165164
Prediction of pregabalin-mediated pain response by severity of sleep disturbance in patients with painful diabetic neuropathy and post-herpetic neuralgiaQ39215784
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P304page(s)1699-1708
P577publication date2018-01-01
P1433published inJournal of Pain ResearchQ6295704
P1476titleComparison of the efficacy and safety of pregabalin for postherpetic neuralgia in Chinese and international patients
P478volume11